Senior Manager, AI & Data Solutions at Bristol-Myers Squibb

Warsaw, Woj. Mazowieckie, Poland

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalIndustries

Requirements

Advanced degree (MS or equivalent) in economics, IT, or digital health-related fields
6–8 years of experience in the pharmaceutical industry or related sectors
Good verbal and written communication skills (both in English and local language)
Experience supporting data transformation initiatives and contributing to AI-based solutions
Solid project coordination and stakeholder engagement skills
Familiarity with tools such as Power BI, Veeva, Salesforce, and GenAI
Proven ability to work effectively across cross-functional teams and global environments

Responsibilities

Support data-driven decision-making by helping translate complex data into clear, actionable insights for commercial teams
Collaborate with stakeholders to identify business challenges and contribute to the development of data & AI strategies that drive differentiation and engagement
Assist in shaping a data strategy that integrates internal and external sources for improved business understanding
Contribute to the automation of data integration, processing, and reporting to improve scalability and efficiency
Help design and implement analytics tools that reduce manual work and enable faster, smarter decisions
Promote the adoption of advanced analytics, including predictive models and machine learning, to elevate organizational maturity
Monitor performance of deployed solutions and suggest enhancements to maximize business impact
Build strong relationships with commercial stakeholders, acting as a trusted partner and advocate for data and technology

Skills

Data Analytics

Business Intelligence

Stakeholder Collaboration

Digital Transformation

Commercial Analytics

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free